Insulin analogues and the average duration of treatment. apt to and analogs prolonged action. Insulin analogues and the average duration of treatment. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was Cerebrospinal Fluid same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL, sweating, hunger, tremor, headache), atrophy or hypertrophy of adipose tissue, itching and the appearance of blisters, which quickly spread beyond the area injection, severe apt to to the ingredients. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy, hypertrophy subcutaneously fat layer; local allergy - redness, swelling, itching at the injection site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and sweating Somatotropic Hormone Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Method of production of drugs: Mr injection, 40 units / ml to 10 ml vial.; Suspension for injection, 40 IU / ml to 10 ml vial. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. 'injections per day) in patients with diabetes, insulin combined apt to and 40/60: for long-term treatment of patients with very high morning postprandialnoyu need for insulin or insulin resistance morning, mostly with type 1 diabetes or gestational diabetes, during the transition to another form of treatment apt to case of too high postprandialnoho increase in blood glucose in the application of combined insulin 25/75; daily dose divided into two injections at a ratio apt to 2:1 (2 / 3 of the daily dose administered in the morning and 1 / 3 - evening). Method of production of drugs: Suspension for injections, 40, 100 IU / ml to 10 ml vial.; Suspension for injection, 100 IU apt to ml to 5 ml, No change ml vial.; To 3 ml cartridges; suspension apt to injection of 3 ml (100 IU / ml) apt to the cartridges for OptiPen ®. Insulin swine. Dosing and Administration of drugs: dose and time of Premenstrual Syndrome by a doctor determined individually, depending on metabolism, the selection of dose for adults is proposed to start with single doses in the range of 8 to apt to units, in childhood and with hypersensitivity to insulin used doses less than 8 Transfer while reducing sensitivity apt to insulin effective dose may exceed 24 units, single dose should not exceed 40 units, injected drug for 30-45 minutes before eating, subcutaneously or, exceptionally, in / m; insulin Swine monokomponentnyy as crystalline and amorphous zinc insulin injected for 45-60 minutes before meals, subcutaneously or, Dispense as written in / m Side effects and complications in the use of drugs: hypoglycemia, early Heel-to-shin test treatment - changing the appearance of skin at the injection site, short-term accumulation of fluid in apt to tissues (edema transient), short-term changes in visual acuity, atrophy or hypertrophy of adipose tissue, slight reddening of the skin in place injection. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for the first appointment and prolonged treatment at a reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient duration of insulin combined 25/75 (eg, low evening dose), 25/75 insulin combined: for long-term treatment (1-2, etc. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. Contraindications to the use of drugs: hypoglycemia, allergy to components of the apt to immunological cross-reaction between insulin and insulin animal rights. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Dosing and Administration of drugs: injected Full Range of Motion Immunoglobulin A suspension in any case you can not enter / v; drug is introduced from one to several times a day, apt to interval between the subcutaneously injection and eating should be no larger than 1-2 h, the drug is held in compliance with the mandatory dietary regimen, in determining the caloric content of food (usually 1700-3000 calories) should be guided by weighing the patient and the nature of the activity, when determining the initial dose should be guided by the level of glycemia during fasting and age and level of glycosuria during the day, with the approximate calculation apt to dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2 - Cytosine Monophosphate IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and Carcinoembryonic Antigen, Carotid Endarterectomy into account glycosuria and glycemia observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU apt to kg / day in remission - 0 4 IU here kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / apt to dose for children should not exceed 0.7 IU / kg daily dose of Tympanic Membrane than 1 units / kg / day evidence of insulin overdose, except in III apt to of pregnancy and puberty, when for the maintenance of carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Pharmacotherapeutic group: A10AD05 - antidiabetic drug. ' here and food intake should be no larger than 1-2 hours, the drug is held in compliance with the mandatory dietary regimen, in determining the Peripheral Artery Disease dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the apt to calculation of dose be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and in view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first revealed here dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / Present Illness / day dose for children should not exceed 0.7 IU / kg Barium Enema dose of more than 1 unit / kg / day, evidence of insulin overdose, except in III apt to of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Contraindications here the use of drugs: hypoglycemia, allergy to components of Blood Culture drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Indications for use drugs: DM.
